Literature DB >> 17377687

Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials.

Randy Mellaerts1, Caroline A Aerts, Jan Van Humbeeck, Patrick Augustijns, Guy Van den Mooter, Johan A Martens.   

Abstract

This in vitro study reports on the enhanced release of the hydrophobic drug itraconazole from the ordered mesoporous SBA-15 silica material and on the existence of a critical mesopore diameter for enhancing release.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17377687     DOI: 10.1039/b616746b

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  20 in total

1.  The biocompatibility of mesoporous silicates.

Authors:  Sarah P Hudson; Robert F Padera; Robert Langer; Daniel S Kohane
Journal:  Biomaterials       Date:  2008-10       Impact factor: 12.479

2.  Spontaneous crystalline-to-amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 3: effect of moisture.

Authors:  Ken K Qian; Dale E Wurster; Robin H Bogner
Journal:  Pharm Res       Date:  2012-03-20       Impact factor: 4.200

Review 3.  Nanoscale delivery systems for microRNAs in cancer therapy.

Authors:  Sanda Boca; Diana Gulei; Alina-Andreea Zimta; Anca Onaciu; Lorand Magdo; Adrian Bogdan Tigu; Calin Ionescu; Alexandru Irimie; Rares Buiga; Ioana Berindan-Neagoe
Journal:  Cell Mol Life Sci       Date:  2019-10-21       Impact factor: 9.261

4.  A solid-state NMR study of amorphous ezetimibe dispersions in mesoporous silica.

Authors:  Frederick G Vogt; Karen Roberts-Skilton; Sonya A Kennedy-Gabb
Journal:  Pharm Res       Date:  2013-06-22       Impact factor: 4.200

5.  Production of a new platform based on fumed and mesoporous silica nanoparticles for enhanced solubility and oral bioavailability of raloxifene HCl.

Authors:  Jaleh Varshosaz; Ladan Dayani; Sana Pirmardvand Chegini; Mohsen Minaiyan
Journal:  IET Nanobiotechnol       Date:  2019-06       Impact factor: 1.847

6.  A Comparative Study of the Pharmaceutical Properties between Amorphous Drugs Loaded-Mesoporous Silica and Pure Amorphous Drugs Prepared by Solvent Evaporation.

Authors:  Arif Budiman; Diah Lia Aulifa
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-09

7.  Characterization of medicinal compounds confined in porous media by neutron vibrational spectroscopy and first-principles calculations: a case study with ibuprofen.

Authors:  Ken K Qian; Wei Zhou; Xiaoming Xu; Terrence J Udovic
Journal:  Pharm Res       Date:  2012-05-15       Impact factor: 4.200

8.  Enhanced antifungal efficacy of tebuconazole using gated pH-driven mesoporous nanoparticles.

Authors:  Núria Mas; Irene Galiana; Silvia Hurtado; Laura Mondragón; Andrea Bernardos; Félix Sancenón; María D Marcos; Pedro Amorós; Nuria Abril-Utrillas; Ramón Martínez-Máñez; José Ramón Murguía
Journal:  Int J Nanomedicine       Date:  2014-05-23

9.  Encapsulation of Anti-Tuberculosis Drugs within Mesoporous Silica and Intracellular Antibacterial Activities.

Authors:  Xin Xia; Kevin Pethe; Ryangyeo Kim; Lluis Ballell; David Barros; Jonathan Cechetto; HeeKyoung Jeon; Kideok Kim; Alfonso E Garcia-Bennett
Journal:  Nanomaterials (Basel)       Date:  2014-09-11       Impact factor: 5.076

10.  Self-Assembly of Pluronic F127-Silica Spherical Core-Shell Nanoparticles in Cubic Close-Packed Structures.

Authors:  Stef Kerkhofs; Tom Willhammar; Heleen Van Den Noortgate; Christine E A Kirschhock; Eric Breynaert; Gustaaf Van Tendeloo; Sara Bals; Johan A Martens
Journal:  Chem Mater       Date:  2015-07-24       Impact factor: 9.811

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.